PCV37 COST-EFFECTIVENESS OF ATORVASTATIN, ROSUVASTATIN, AND SIMVASTATIN IN REDUCING LDL-CHOLESTEROL TO MEET THE EUROPEAN TARGET LEVEL—BAYESIAN META-ANALYSIS AND SIMULATION Peura P1. Martikainen JA1, Hallinen T1, Soini EJ1, Niskanen L2 Unive ...
Abstract
Authors